Davis Jennifer L.
SEC CIK 1916665 · EDGAR
BoughtSold
Most active insiders at ABBV, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Siatis Perry C | EVP, GC AND Sec | — | $9.52M |
| 2 | Donoghoe Nicholas | EVP, CHIEF BUS, STRAT Off | — | $8.18M |
| 3 | Purdue David Ryan | SVP, Ctrl | — | $1.22M |
| 4 | Crum Demetris D | EVP, Chief HR Off | — | — |
| 5 | Thakkar Roopal | EVP, CSO, R, D | — | — |
| 6 | Quaggin Susan E | Dir | — | — |
| 7 | Reents Scott T | EVP, CFO | — | — |
| 8 | Davis Jennifer L. | Dir | — | — |
| 9 | Stewart Jeffrey Ryan | EVP, Chief COMMERCIAL Off | — | — |
| 10 | MEYER MELODY B | Dir | — | — |
Transactions 27
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-12 17:00 | 2026-05-08 | ABBV | AbbVie | Davis Jennifer L. | Dir | A - Grant | $0.00 | +1,118 | 3,643 | +44% | $0 | |
| D | 2025-12-05 | 2025-12-03 | PG | Procter & Gamble | Davis Jennifer L. | CEO - Health Care | M - OptEx | $144.35 | +60.43 | 61.8K | +0.1% | +$8,723 |
| D | 2025-12-05 | 2025-12-03 | PG | Procter & Gamble | Davis Jennifer L. | CEO - Health Care | F - Tax | $144.35 | -60.43 | 61.8K | -0.1% | -$8,723 |
| 2025-10-06 | 2025-10-02 | PG | Procter & Gamble | Davis Jennifer L. | CEO - Health Care | S - Sale | $152.23 | -3,227 | 61.8K | -5% | -$491.2K | |
| 2025-08-21 | 2025-08-19 | PG | Procter & Gamble | Davis Jennifer L. | CEO - Health Care | S - Sale | $157.27 | -8,596 | 65.0K | -12% | -$1.35M | |
| D | 2025-08-20 | 2025-08-18 | PG | Procter & Gamble | Davis Jennifer L. | CEO - Health Care | A - Grant | $0.00 | +21.5K | 73.6K | +41% | $0 |
| 2025-05-13 | 2025-05-09 | ABBV | AbbVie | Davis Jennifer L. | Dir | A - Grant | $0.00 | +1,203 | 2,525 | +91% | $0 | |
| D | 2025-04-30 | 2025-04-29 | PG | Procter & Gamble | Davis Jennifer L. | CEO - Health Care | S - Sale | $161.38 | -1,000 | 52.0K | -2% | -$161.4K |
| D | 2024-12-20 | 2024-12-19 | PG | Procter & Gamble | Davis Jennifer L. | CEO - Health Care | F - Tax | $169.79 | -46.27 | 52.9K | -0.1% | -$7,856 |
| D | 2024-12-20 | 2024-12-19 | PG | Procter & Gamble | Davis Jennifer L. | CEO - Health Care | M - OptEx | $169.79 | +46.27 | 53.0K | +0.1% | +$7,856 |
| D | 2024-10-03 | 2024-10-02 | PG | Procter & Gamble | Davis Jennifer L. | CEO - Health Care | S - Sale | $171.65 | -4,447 | 52.9K | -8% | -$763.3K |
| D | 2024-08-22 | 2024-08-20 | PG | Procter & Gamble | Davis Jennifer L. | CEO - Health Care | S - Sale | $169.22 | -6,223 | 57.3K | -10% | -$1.05M |
| 2024-08-20 | 2024-08-19 | PG | Procter & Gamble | Davis Jennifer L. | CEO - Health Care | A - Grant | $0.00 | +16.0K | 63.4K | +34% | $0 | |
| 2024-05-07 | 2024-05-03 | ABBV | AbbVie | Davis Jennifer L. | Dir | A - Grant | $0.00 | +1,322 | 1,322 | New | $0 | |
| D | 2023-12-08 | 2023-12-06 | PG | Procter & Gamble | Davis Jennifer L. | CEO - Health Care | M - OptEx | $149.40 | +47.58 | 47.3K | +0.1% | +$7,108 |
| D | 2023-12-08 | 2023-12-06 | PG | Procter & Gamble | Davis Jennifer L. | CEO - Health Care | F - Tax | $149.40 | -47.58 | 47.3K | -0.1% | -$7,108 |
| 2023-08-21 | 2023-08-17 | PG | Procter & Gamble | Davis Jennifer L. | CEO - Health Care | S - Sale | $152.85 | -5,761 | 47.1K | -11% | -$880.6K | |
| D | 2023-08-18 | 2023-08-16 | PG | Procter & Gamble | Davis Jennifer L. | CEO - Health Care | A - Grant | $0.00 | +12.8K | 52.9K | +32% | $0 |
| D | 2023-04-25 | 2023-04-24 | PG | Procter & Gamble | Davis Jennifer L. | CEO - Health Care | S - Sale+OE | $155.27 | -23.9K | 39.9K | -38% | -$3.72M |
| D | 2023-04-25 | 2023-04-24 | PG | Procter & Gamble | Davis Jennifer L. | CEO - Health Care | M - OptEx | $78.52 | +23.9K | 63.8K | +60% | +$1.88M |
| D | 2022-12-09 | 2022-12-07 | PG | Procter & Gamble | Davis Jennifer L. | CEO - Health Care | M - OptEx | $149.18 | +37.47 | 39.8K | +0.1% | +$5,590 |
| D | 2022-12-09 | 2022-12-07 | PG | Procter & Gamble | Davis Jennifer L. | CEO - Health Care | F - Tax | $149.18 | -37.47 | 39.7K | -0.1% | -$5,590 |
| D | 2022-10-04 | 2022-10-03 | PG | Procter & Gamble | Davis Jennifer L. | CEO - Health Care | A - Grant | $0.00 | +6,746 | 39.6K | +21% | $0 |
| D | 2022-08-24 | 2022-08-23 | PG | Procter & Gamble | Davis Jennifer L. | CEO - Health Care | M - OptEx | $91.07 | +27.8K | 60.7K | +85% | +$2.53M |
| D | 2022-08-24 | 2022-08-23 | PG | Procter & Gamble | Davis Jennifer L. | CEO - Health Care | S - Sale+OE | $147.95 | -27.8K | 32.9K | -46% | -$4.11M |
| D | 2022-08-18 | 2022-08-17 | PG | Procter & Gamble | Davis Jennifer L. | CEO - Health Care | S - Sale | $149.33 | -7,621 | 32.9K | -19% | -$1.14M |
| D | 2022-08-18 | 2022-08-16 | PG | Procter & Gamble | Davis Jennifer L. | CEO - Health Care | A - Grant | $0.00 | +19.0K | 40.5K | +88% | $0 |
Purchase Sale Sale after option exercise All abbreviations